REGENERON PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2011 to Q3 2024.
  • Regeneron Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was 13.2 %, a 0.99% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Return On Assets for 2023 was 12.6 %, a 20.1% decline from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Return On Assets for 2022 was 15.7 %, a 57% decline from 2021.
  • Regeneron Pharmaceuticals, Inc. annual Return On Assets for 2021 was 36.6 %, a 65% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 13.2 +0.13 +0.99% Jul 1, 2024 Sep 30, 2024
Q2 2024 12.7 -1.88 -12.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 11.9 -2.81 -19.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 12.6 -3.16 -20.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 13.1 -7.06 -35.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 14.6 -7.54 -34% Apr 1, 2023 Jun 30, 2023
Q1 2023 14.7 -18.1 -55.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 15.7 -20.8 -57% Oct 1, 2022 Dec 31, 2022
Q3 2022 20.1 -14.8 -42.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 22.2 -12.1 -35.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 32.7 +8.27 +33.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 36.6 +14.4 +65% Oct 1, 2021 Dec 31, 2021
Q3 2021 34.9 +14.3 +69% Jul 1, 2021 Sep 30, 2021
Q2 2021 34.2 +14 +69% Apr 1, 2021 Jun 30, 2021
Q1 2021 24.5 +8.66 +54.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 22.2 +6.7 +43.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 20.7 +4.08 +24.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 20.3 +3.21 +18.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 15.8 -5.61 -26.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 15.5 -7.9 -33.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 16.6 -1.9 -10.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 17 -0.26 -1.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 21.4 +5.07 +31% Jan 1, 2019 Mar 31, 2019
Q4 2018 23.4 +9 +62.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 18.5 +2.31 +14.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 17.3 +1.76 +11.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 16.3 +2.5 +18.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 14.4 +0.53 +3.83% Oct 1, 2017 Dec 31, 2017
Q3 2017 16.2 +3.18 +24.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 15.5 +2.56 +19.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 13.8 -0.13 -0.93% Jan 1, 2017 Mar 31, 2017
Q4 2016 13.8 +0.79 +6.06% Oct 1, 2016 Dec 31, 2016
Q3 2016 13 +0.12 +0.93% Jul 1, 2016 Sep 30, 2016
Q2 2016 13 +2.08 +19.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 14 +4.89 +53.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 13 +3.57 +37.7% Oct 1, 2015 Dec 31, 2015
Q3 2015 12.9 +2.59 +25.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 10.9 -2.19 -16.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 9.08 -4.94 -35.2% Jan 1, 2015 Mar 31, 2015
Q4 2014 9.46 -7.11 -42.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 10.3 -23.8 -69.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 13.1 -27.3 -67.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 14 -30.8 -68.7% Jan 1, 2014 Mar 31, 2014
Q4 2013 16.6 -29.3 -63.8% Oct 1, 2013 Dec 31, 2013
Q3 2013 34.1 +18.4 +118% Jul 1, 2013 Sep 30, 2013
Q2 2013 40.4 +42.6 Apr 1, 2013 Jun 30, 2013
Q1 2013 44.8 +59 Jan 1, 2013 Mar 31, 2013
Q4 2012 45.8 +65.9 Oct 1, 2012 Dec 31, 2012
Q3 2012 15.6 +33.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -2.14 +12.7 +85.6% Apr 1, 2012 Jun 30, 2012
Q1 2012 -14.2 -2.12 -17.6% Jan 1, 2012 Mar 31, 2012
Q4 2011 -20 Oct 1, 2011 Dec 31, 2011
Q3 2011 -17.5 Jul 1, 2011 Sep 30, 2011
Q2 2011 -14.9 Apr 1, 2011 Jun 30, 2011
Q1 2011 -12.1 Jan 1, 2011 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.